.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC30_AcetylsalicylicAcidAndDi.AcetylsalicylicAcidAndDi .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC30_AcetylsalicylicAcidAndDi.AcetylsalicylicAcidAndDi| name: | AcetylsalicylicAcidAndDipyridamoleCombination | |
| ATC code: | B01AC30 | route: | oral |
| compartments: | 1 | |
| dosage: | 200 | mg |
| volume of distribution: | 4 | L |
| clearance: | 2 | L/h/kg |
| other parameters in model implementation | ||
This combination includes acetylsalicylic acid (aspirin) and dipyridamole, both of which are antithrombotic agents. It is used to reduce the risk of stroke in patients with a history of transient ischemic attacks or completed thrombotic stroke. The combination is approved and marketed in many countries, often as an extended-release oral formulation.
Pharmacokinetic parameters estimated for healthy adults; no dedicated population PK publication available.